CellCentric has an international investor base of highly experienced, long term investors, led by Morningside Venture Investments.
Other funding has come from Providence Investment Company, Takeda Ventures Inc, The UK Innovation Science & Seed Fund, Avlar BioVentures, NESTA, and the University of Cambridge.
Our lead investors
CellCentric’s lead investors are Morningside Venture Investments Ltd and Providence Investment Company Ltd.
Other funding has come from the Takeda Ventures Inc, The Rainbow Seed Fund, Avlar BioVentures, NESTA, and Cambridge University.